Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.
<h4>Background</h4>Arterial stiffness is increased in patients with CKD and is a powerful predictor of cardiovascular morbidity and mortality. Use of the xanthine oxidase inhibitor allopurinol has been shown to improve endothelial function, reduce left ventricular hypertrophy and possibl...
Saved in:
| Main Authors: | Khai P Ng, Stephanie J Stringer, Mark D Jesky, Punit Yadav, Rajbir Athwal, Mary Dutton, Charles J Ferro, Paul Cockwell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0091961 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
by: Mark D Jesky, et al.
Published: (2016-01-01) -
Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease.
by: Anthony Fenton, et al.
Published: (2017-01-01) -
Effectiveness of Allopurinol on Uric Acid and Pediatric Chronic Kidney Disease Severity in the Chronic Kidney Disease in Children Study
by: Derek K. Ng, et al.
Published: (2025-07-01) -
Effect of allopurinol on albuminuria in type 2 diabetic kidney disease with hyperuricemia
by: CHEN Wen-hui, et al.
Published: (2017-01-01) -
Effect of allopurinol on renal function in chronic kidney disease patients with asymptomatic hyperuricemia
by: 王垚, et al.
Published: (2017-01-01)